SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27 | -43.8% | 15,146 | 0.0% | 0.00% | – |
| Q4 2022 | $48 | -100.0% | 15,146 | -46.4% | 0.00% | -100.0% |
| Q2 2022 | $117,000 | -42.9% | 28,246 | -19.9% | 0.00% | 0.0% |
| Q1 2022 | $205,000 | -22.3% | 35,246 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $264,000 | -17.0% | 35,246 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $318,000 | -24.6% | 35,246 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $422,000 | +92.7% | 35,246 | +102.0% | 0.00% | +100.0% |
| Q1 2021 | $219,000 | -19.5% | 17,446 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $272,000 | +64.8% | 17,446 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $165,000 | -47.1% | 17,446 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $312,000 | -65.6% | 34,892 | -63.3% | 0.00% | -94.4% |
| Q1 2019 | $906,000 | -17.0% | 95,000 | 0.0% | 0.02% | -18.2% |
| Q4 2018 | $1,091,000 | -88.2% | 95,000 | -82.6% | 0.02% | -80.7% |
| Q3 2018 | $9,238,000 | +82.2% | 545,000 | +52.7% | 0.11% | +14.0% |
| Q2 2018 | $5,069,000 | – | 357,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |